Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polysynaptic spinal and supraspinal reflex pathways are complex neural circuits that involve multiple interneurons to coordinate motor responses to sensory stimuli (Source: StatPearls, NBK513223). Unlike simple monosynaptic reflexes, these pathways integrate peripheral sensory input with descending modulatory signals from higher brain centers, such as the brainstem and cerebral cortex, to regulate muscle tone and protective withdrawal movements (Source: Neuroscience, 2nd edition, Purves et al.). These pathways are the primary physiological targets for centrally acting skeletal muscle relaxants used to treat conditions like acute muscle spasms and chronic spasticity (Source: PubMed, PMID: 1261155). Drugs such as cyclobenzaprine act primarily at the supraspinal level, specifically within the brainstem, to reduce tonic somatic motor activity (Source: FDA Label, Flexeril). Other agents like baclofen act at the spinal level as GABA-B agonists to inhibit both monosynaptic and polysynaptic reflex arcs (Source: StatPearls, NBK507908). Dysfunction in these pathways, often due to spinal cord injury or multiple sclerosis, results in a loss of inhibitory control, leading to hyperreflexia and debilitating motor symptoms (Source: Journal of Neurology, Neurosurgery & Psychiatry).
Depression of polysynaptic reflex arcs through the modulation of interneuronal activity in the spinal cord and brainstem, typically involving GABAergic, glycinergic, or adrenergic signaling to reduce motor neuron excitability.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polysynaptic spinal and supraspinal reflex pathways.